FDA Alert : Multaq (Dronedarone) Increased Risk Of Death / Cardiovascular Problems
Medical News Today
A trial of the drug in heart failure was stopped as an interim analysis showed a possible increase in heart failure deaths, in patients with moderate to severe Coronary Heart Failure. Chemically, dronedarone is a benzofuran derivative related to ...
Heart drug doubles risk for heart failureallvoices
Sanofi's Multaq Losing Rhythm?NASDAQ
FDA Further Restricts Use of Sanofi's MultaqWall Street Journal
Xinhua -Forbes -The Open Press (press release)
all 153 news articles »